Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J F Chong

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Redox Biology|June 9, 2020
Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-MycDeepika Raman, Stephen J F Chong, Kartini Iskandar, et al.
Redox Biology|June 20, 2021
The redox-senescence axis and its therapeutic targetingNatalie Yl Ngoi, Angeline Qx Liew, Stephen J F Chong, et al.
Blood Neoplasia|June 30, 2026
Inhibition of PRMT5 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptotic cell deathFen Zhu, Jing Wang, Christine E Ryan, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Leukemia|July 24, 2025
Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignanciesStephen J F Chong, Jolin X H Lai, Kartini Iskandar, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitorsRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Blood|February 18, 2021
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Christoph Kornauth, Stéphanie Poulain, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Redox Biology|June 9, 2020
Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-MycDeepika Raman, Stephen J F Chong, Kartini Iskandar, et al.
Redox Biology|June 20, 2021
The redox-senescence axis and its therapeutic targetingNatalie Yl Ngoi, Angeline Qx Liew, Stephen J F Chong, et al.
Blood Neoplasia|June 30, 2026
Inhibition of PRMT5 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptotic cell deathFen Zhu, Jing Wang, Christine E Ryan, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Leukemia|July 24, 2025
Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignanciesStephen J F Chong, Jolin X H Lai, Kartini Iskandar, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitorsRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Blood|February 18, 2021
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Christoph Kornauth, Stéphanie Poulain, et al.
Pageof 1